Constantijn J.M. Halkes

3.1k citations

60 papers · 1.2k indexed · h-index 20

Hematology top 2%
- Hematopoietic Stem Cell Transplantation 27
- Acute Myeloid Leukemia Research 17
Immunology top 10%
- T-cell and B-cell Immunology 16
- Immune Cell Function and Interaction 15
- Immunotherapy and Immune Responses 5
Endocrinology, Diabetes and Metabolism top 10%
- Diabetes, Cardiovascular Risks, and Lipoproteins 8
Epidemiology top 10%
- Cytomegalovirus and herpesvirus research 7
Transplantation top 10%
Public Health, Environmental and Occupational Health
- Acute Lymphoblastic Leukemia research 8

Co-authors: Manuel Castro Cabezas J.H. Frederik Falkenburg D.W. Erkelens Erik W.A. Marijt Peter P.T. de Jaegere Marieke Griffioen Inge Jedema J.P.H. van Wijk
Cited by: Hematology Immunology Endocrinology, Diabetes and Metabolism
Journals: Journal of Clinical Investigation (1 paper)Blood (10 papers)The Journal of Immunology (1 paper)
Partner nations: Netherlands Germany Italy

In The Last Decade

Constantijn J.M. Halkes

56 papers receiving 1.2k citations

Peers

Countries citing papers authored by Constantijn J.M. Halkes

Since Specialization

Citations

This map shows the geographic impact of Constantijn J.M. Halkes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Constantijn J.M. Halkes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Constantijn J.M. Halkes more than expected).

Fields of papers citing papers by Constantijn J.M. Halkes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Constantijn J.M. Halkes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Constantijn J.M. Halkes. The network helps show where Constantijn J.M. Halkes may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Constantijn J.M. Halkes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Constantijn J.M. Halkes Line = papers co-authored together Constantijn J.M. Halkes links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Risk factors for graft-versus-host-disease after donor lymphocyte infusion following T-cell depleted allogeneic stem cell transplantation Frontiers in Immunology ·Eva A. S. Koster,Peter A. von dem Borne,Peter van Balen,Erik W.A. Marijt,Jennifer M.L. Tjon,Tjeerd J.F. Snijders,Daniëlle van Lammeren,Hendrik Veelken,J.H. Frederik Falkenburg,Constantijn J.M. Halkes,Liesbeth C. de Wreede	2024	2
2	Expanding the repertoire reveals recurrent, cryptic, and hematopoietic HLA class I minor histocompatibility antigens Blood ·Kyra J. Fuchs,Marian van de Meent,M. Willy Honders,Indu Khatri,Michel G.D. Kester,Eva A. S. Koster,Georgia Koutsoumpli,Arnoud H. de Ru,Cornelis A.M. van Bergen,Peter A. van Veelen,Peter A.C. ’t Hoen,Peter van Balen,Erik B. van den Akker,Hendrik Veelken,Constantijn J.M. Halkes,J.H. Frederik Falkenburg,Marieke Griffioen	2024	6
3	A transcriptomic based deconvolution framework for assessing differentiation stages and drug responses of AML npj Precision Oncology ·Emin Onur Karakaslar,Jeppe F. Severens,Elena Sánchez‐López,Peter A. van Veelen,Mihaela Zlei,Jacques J. M. van Dongen,Annemarie M. Otte,Constantijn J.M. Halkes,Peter van Balen,Hendrik Veelken,Marcel Reinders,Marieke Griffioen,Erik B. van den Akker	2024	5
4	Feasibility, safety, and efficacy of early prophylactic donor lymphocyte infusion after T cell-depleted allogeneic stem cell transplantation in acute leukemia patients Annals of Hematology ·Boris van der Zouwen,Eva A. S. Koster,Peter A. von dem Borne,L. E. M. Oosten,M. W. I. Roza-Scholten,Tjeerd J.F. Snijders,Daniëlle van Lammeren,Peter van Balen,Erik W.A. Marijt,Hendrik Veelken,J.H. Frederik Falkenburg,L. C. de Wreede,Constantijn J.M. Halkes	2023	4
5	Upfront Alternative Donor Transplant versus Immunosuppressive Therapy in Patients with Severe Aplastic Anemia Who Lack a Fully HLA-Matched Related Donor: Systematic Review and Meta-Analysis of Retrospective Studies, on Behalf of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation Transplantation and Cellular Therapy ·Hind Alotaibi,Mahmoud Aljurf,Régis de Latour,Mansour Alfayez,Andrea Bacigalupo,Riad El Fakih,Hubert Schrezenmeier,Syed Osman Ahmed,Éliane Gluckman,Shahid Iqbal,Britta Höchsmann,Constantijn J.M. Halkes,Josu de la Fuente,Nawal F Alshehry,Simone Cesaro,Jakob Passweg,Carlo Dufour,Antonio M. Risitano,John F. DiPersio,Ibraheem Motabi	2021	12
6	Haploidentical hematopoietic stem cell transplantation in aplastic anemia: a systematic review and meta-analysis of clinical outcome on behalf of the severe aplastic anemia working party of the European group for blood and marrow transplantation (SAAWP of EBMT) Bone Marrow Transplantation ·Ghada Elgohary,Riad El Fakih,Régis de Latour,Antonio M. Risitano,Judith Marsh,Hubert Schrezenmeier,Éliane Gluckman,Britta Höchsmann,Filomena Pierri,Constantijn J.M. Halkes,Hazzaa Alzahrani,Josu de la Fuente,Simone Cesaro,Ali Alahmari,Syed Osman Ahmed,Jakob Passweg,Carlo Dufour,Andrea Bacigalupo,Mahmoud Aljurf	2020	40
7	Generation and infusion of multi-antigen-specific T cells to prevent complications early after T-cell depleted allogeneic stem cell transplantation—a phase I/II study Leukemia ·Marthe C.J. Roex,Peter van Balen,Lothar Germeroth,Lois Hageman,Esther van Egmond,Sabrina A.J. Veld,Conny Hoogstraten,Ellis van Liempt,Jaap Jan Zwaginga,Liesbeth C. de Wreede,Pauline Meij,Ann C.T.M. Vossen,Sophia Danhof,Hermann Einsele,M. Ron Schaafsma,Hendrik Veelken,Constantijn J.M. Halkes,Inge Jedema,J.H. Frederik Falkenburg	2019	19
8	Impact of alemtuzumab pharmacokinetics on T-cell dynamics, graft-versus-host disease and viral reactivation in patients receiving allogeneic stem cell transplantation with an alemtuzumab-based T-cell-depleted graft Transplant Immunology ·Floris C. Loeff,Esther H.M. van Egmond,Dirk Jan A. R. Moes,Charissa Wijnands,Peter A. von dem Borne,Hendrik Veelken,J.H. Frederik Falkenburg,Inge Jedema,Constantijn J.M. Halkes	2019	8
9	Relapse of Aplastic Anemia with Majority Donor Chimerism (Donor-Type Aplasia) Occurring Late after Bone Marrow Transplantation Biology of Blood and Marrow Transplantation ·Abigail Shaw,Jakob Passweg,Josu de la Fuente,Rajinder Bajwa,Jerry Stein,Abdulhadi Al‐Zaben,Constantijn J.M. Halkes,Alice Norton,Michelle Cummins,John Moppett,Mayada Abu Shanap,Colin G. Steward	2019	9
10	Impact of induction regimen and allogeneic hematopoietic cell transplantation on outcome in younger adults with acute myeloid leukemia with a monosomal karyotype Haematologica ·Frédéric Baron,Marian Stevens‐Kroef,Michal Kiciński,Giovanna Meloni,Petra Muus,Jean‐Pierre Marie,Constantijn J.M. Halkes,Xavier Thomas,Radovan Vrḫovac,Francesco Albano,François Lefrère,Simona Sica,Marco Mancini,Adriano Venditti,Anne Hagemeijer,Joop H. Jansen,Sergio Amadori,Théo de Witte,R. Willemze,Stefan Suciu	2018	7
11	CMV seronegative donors: Effect on clinical severity of CMV infection and reconstitution of CMV-specific immunity Transplant Immunology ·Pim L. J. van der Heiden,H.M. van Egmond,Sabrina A.J. Veld,Marian van de Meent,M. Eefting,Liesbeth C. de Wreede,Constantijn J.M. Halkes,J.H. Frederik Falkenburg,Erik W.A. Marijt,Inge Jedema	2018	6
12	CD4 Donor Lymphocyte Infusion Can Cause Conversion of Chimerism Without GVHD by Inducing Immune Responses Targeting Minor Histocompatibility Antigens in HLA Class II Frontiers in Immunology ·Peter van Balen,Cornelis A.M. van Bergen,Simone A.P. van Luxemburg-Heijs,Wendy de Klerk,Esther H.M. van Egmond,Sabrina A.J. Veld,Constantijn J.M. Halkes,Jaap Jan Zwaginga,Marieke Griffioen,Inge Jedema,J.H. Frederik Falkenburg	2018	27
13	Multi-state analysis illustrates treatment success after stem cell transplantation for acute myeloid leukemia followed by donor lymphocyte infusion Haematologica ·M. Eefting,Liesbeth C. de Wreede,Constantijn J.M. Halkes,Peter A. von dem Borne,Sabina Kersting,Erik W.A. Marijt,Hendrik Veelken,Hein Putter,Johannes Schetelig,J.H. Frederik Falkenburg	2016	30
14	Effectivity of a strategy in elderly AML patients to reach allogeneic stem cell transplantation using intensive chemotherapy: Long-term survival is dependent on complete remission after first induction therapy Leukemia Research ·Peter A. von dem Borne,Liesbeth C. de Wreede,Constantijn J.M. Halkes,Erik W.A. Marijt,JH Falkenburg,Hendrik Veelken	2016	13
15	Idarubicin and cytarabine in combination with gemtuzumab ozogamicin (IAGO) for untreated patients with high-risk MDS or AML evolved from MDS: a phase II study from the EORTC and GIMEMA Leukemia Groups (protocol 06013) Annals of Hematology ·Théo de Witte,Stefan Suciu,Liv Meert,Constantijn J.M. Halkes,Dominik Selleslag,Dominique Bron,Sergio Amadori,Roel Willemze,Petra Muus,Frédéric Baron	2015	10
16	Patient HLA-DP–Specific CD4+ T Cells from HLA-DPB1–Mismatched Donor Lymphocyte Infusion Can Induce Graft-versus-Leukemia Reactivity in the Presence or Absence of Graft-versus-Host Disease Biology of Blood and Marrow Transplantation ·Caroline E. Rutten,Simone A.P. van Luxemburg-Heijs,Constantijn J.M. Halkes,Cornelis A.M. van Bergen,Erik W.A. Marijt,Machteld Oudshoorn,Marieke Griffioen,J.H. Frederik Falkenburg	2012	46
17	Effective Treatment of Refractory CMV Reactivation After Allogeneic Stem Cell Transplantation With In Vitro-generated CMV pp65-specific CD8+ T-cell Lines Journal of Immunotherapy ·Pauline Meij,Inge Jedema,Maarten L. Zandvliet,Pim L. J. van der Heiden,Marian van de Meent,H. M. Esther van Egmond,Ellis van Liempt,Conny Hoogstraten,Simone Kruithof,Sabrina A.J. Veld,Erik W.A. Marijt,Peter A. von dem Borne,Arjan C. Lankester,Constantijn J.M. Halkes,J.H. Frederik Falkenburg	2012	46
18	The Y238X Stop Codon Polymorphism in the Human β-Glucan Receptor Dectin-1 and Susceptibility to Invasive Aspergillosis The Journal of Infectious Diseases ·Louis Yi Ann Chai,Mark de Boer,Walter J. F. M. van der Velden,Theo S. Plantinga,Annemiek B. van Spriel,Cor Jacobs,Constantijn J.M. Halkes,Alieke G. Vonk,Nicole M. A. Blijlevens,Jaap T. van Dissel,Peter Donnelly,Bart Jan Kullberg,Johan Maertens,Mihai G. Netea	2011	88
19	Effects of increasing doses of simvastatin on fasting lipoprotein subfractions, and the effect of high-dose simvastatin on postprandial chylomicron remnant clearance in normotriglyceridemic patients with premature coronary sclerosis Atherosclerosis ·J.P.H. van Wijk,Rudolf J.A Buirma,Arie van Tol,Constantijn J.M. Halkes,Peter P.T. de Jaegere,H. W. M. Plokker,Yvonne J.M. van der Helm,Manuel Castro Cabezas	2004	20
20	Fasting and daylong triglycerides in obesity with and without type 2 diabetes Metabolism ·J.P.H. van Wijk,Constantijn J.M. Halkes,D.W. Erkelens,Manuel Castro Cabezas	2003	52

About Constantijn J.M. Halkes

Constantijn J.M. Halkes is a scholar working on Hematology, Immunology and Endocrinology, Diabetes and Metabolism, having authored 60 papers that have together received 1.2k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (27 papers), Acute Myeloid Leukemia Research (17 papers), T-cell and B-cell Immunology (16 papers), Immune Cell Function and Interaction (15 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers), Acute Lymphoblastic Leukemia research (8 papers), Cytomegalovirus and herpesvirus research (7 papers) and Immunotherapy and Immune Responses (5 papers). The work is most often cited by research in Hematology (418 citations), Immunology (398 citations) and Endocrinology, Diabetes and Metabolism (184 citations). Constantijn J.M. Halkes has collaborated with scholars based in Netherlands, Germany and Italy. Frequent co-authors include Manuel Castro Cabezas, J.H. Frederik Falkenburg, D.W. Erkelens, Erik W.A. Marijt, Peter P.T. de Jaegere, Marieke Griffioen, Inge Jedema, J.P.H. van Wijk, Peter A. von dem Borne and Hendrik Veelken. Their work appears in journals such as Journal of Clinical Investigation, Blood and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact